ATAI Life Sciences
ATAI
ATAI
96 hedge funds and large institutions have $19.1M invested in ATAI Life Sciences in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less funds holding
Funds holding: 97 → 96 (-1)
19% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 26
28% less capital invested
Capital invested by funds: $26.3M → $19.1M (-$7.24M)
Holders
96
Holding in Top 10
1
Calls
$316K
Puts
$40K
Top Buyers
| 1 | +$1.41M | |
| 2 | +$554K | |
| 3 | +$113K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$64K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$39.1K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$883K | |
| 3 | -$148K | |
| 4 |
Two Sigma Investments
New York
|
-$124K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$86.2K |